The Union Health Ministry expressed concerns on e-pharmacy over "free-run " of medicines especially sedatives and mood-altering drugs, illegal profiling of buyers and unlawful data collection, calling it 'too dangerous'.  

Mentioning consumer safety as the primary focus, the ministry is in action to finalise and implement the draft on e-pharmacy rules. 

Currently, Drugs and Cosmetics Act , 1940 regulates the import, manufacturing and distribution of drugs.        

Previously, the Drug Controller General of India (DCGI) sent show-cause notices to 20-odd e-pharmacies including Tata 1mg, NetMeds, Practo etc. stating the selling of drugs that are not for retail sale and should only be done by a pharmacist.       

As per E- pharmacy market in India 2022-27 report, the market has flourished tremendously for providing superior and practical solution to customer problems and is expected to rise from its current worth of ₹25.50 billion in 2022 to ₹89.47 billion in 2027 at a compound annual growth rate (CAGR) of 22.20%.